Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Nelson M Podzamczer D
Verxve 144-Week Results: Nevirapine Extended Release (NVP XR) Qd Versus NVP Immediate Release (IR) Bid With FTC/TDF in Treatment-Naive HIV-1 Patients
Journal of AIDS & Clinical Research
Related publications
Quetiapine Modified‐release Versus Immediate‐release in Early Psychosis
Progress in Neurology and Psychiatry
Psychiatry
Mental Health
Neurology
Psychiatric Mental Health
Cost-Effectiveness of DTG + ABC/3TC Versus EFV/TDF/FTC for First-Line Treatment of HIV-1 in the United States
Journal of Medical Economics
Health Policy
Switching to Coformulated Rilpivirine (RPV), Emtricitabine (FTC) and Tenofovir Alafenamide From Either RPV, FTC and Tenofovir Disoproxil Fumarate (TDF) or Efavirenz, FTC and TDF: 96-Week Results From Two Randomized Clinical Trials
HIV Medicine
Health Policy
Infectious Diseases
Pharmacology
Single- And Multiple-Dose Pharmacokinetics of Biphasic Immediate-Release/Extended-Release Hydrocodone Bitartrate/Acetaminophen (MNK-155) Compared With Immediate-Release Hydrocodone Bitartrate/Ibuprofen and Immediate-Release Tramadol HCl/acetaminophen
Journal of Pain Research
Anesthesiology
Pain Medicine
Effect of Extended-Release Naltrexone (XR-NTX) on Quality of Life in Alcohol-Dependent Patients
Alcoholism: Clinical and Experimental Research
Medicine
Psychiatry
Mental Health
Toxicology
Presence of Tablet Remnants of Nevirapine Extended-Release in Stools and Its Impact on Virological Outcome in HIV-1-Infected Patients: A Prospective Cohort Study
PLoS ONE
Multidisciplinary
Pharmacokinetic Simulations of Topiramate Plasma Concentrations Following Dosing Irregularities With Extended-Release vs. Immediate-Release Formulations
Epilepsy and Behavior
Neurology
Behavioral Neuroscience
Switch From Immediate-Release Pramipexole to Extended-Release Pramipexole: The Safety and Efficacy Characteristics of Sixty-Eight Patients
Turk Noroloji Dergisi
Neurology
96-Week Results of Abacavir/Lamivudine Versus Tenofovir/Emtricitabine, Plus Efavirenz, in Antiretroviral-Naive, HIV-1-infected Adults: ASSERT Study
Antiviral Therapy
Infectious Diseases
Pharmacology